Here's a little more info from AOL
Novavax, Inc.
AMEX : NOX
Sector : Healthcare
Industry: Biotechnology & Drugs
Novavax, Inc. is a biopharmaceutical company focusing on the research and development of proprietary topical and oral drug delivery technologies. For the 6 months ended 6/30/98, revenues totalled $325K, up from $150K. Net loss applicable to Common increased 4% to $2.4M. Revenues reflect subcontracts to supply new chemical structures. Higher loss reflects the payment of $455K Preferred Stock dividends and increases in legal expenses. Novavax, Inc.
8320 Guilford Road
Columbia, MD 21046
Phone:(301) 854-3900
Fax:(301) 854-3901
--------------------------------------------------------------------------------
Sector: Healthcare
Industry: Biotechnology & Drugs
Employees: 15
Market Cap (Mil) $ : 17.72
Complete Financials: Jun 1998
Updated: 09/12/1998
Earnings Announcements:
NA
Click Here For Advanced Charting
OFFICERS: Ronald H. Walker, Chmn., Richard F. Maradie, CEO, Brenda L. Fugagli, Sr. VP/Treas./CFO/CAO, David A. White, Secy. TRANSFER AGENT: State Street Bank and Trust Co. Company incorporated 1987 in DE. Direct inquiries to :Brenda L. Fugagli, Sr. VP/Treas./CFO/CAO.
Key Ratios & Statistics
Price & Volume
Recent Price $ 1.44
52 Week High $ 6.13
52 Week Low $ 1.31
Avg Daily Vol (Mil) 0.02
Beta 2.39
Share Related Items
Mkt. Cap. (Mil) $ 17.72
Shares Out (Mil) 12.32
Float (Mil) 6.30
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio (TTM) % 0.00
Financial Strength
Quick Ratio (MRQ) 31.63
Current Ratio (MRQ) 32.03
LT Debt/Equity (MRQ) 0.00
Total Debt/Equity (MRQ) 0.01
Valuation Ratios
Price/Earnings (TTM) NM
Price/Sales (TTM) 24.84
Price/Book (MRQ) 3.62
Price/Cash Flow (TTM) -3.93
Per Share Data
Earnings (TTM) $ -0.39
Sales (TTM) $ 0.06
Book Value (MRQ) $ 0.40
Cash Flow (TTM) $ -0.37
Cash (MRQ) $ 0.69
Mgmt Effectiveness
Return on Equity (TTM) -71.63
Return on Assets (TTM) -45.53
Return on Investment (TTM) -47.06
Profitability
Gross Margin (TTM) % 100.00
Operating Margin (TTM) % NM
Profit Margin (TTM) % NM
Mil = Millions MRQ = Most Recent Quarter TTM = Trailing Twelve Months
GROWTH RATES
1 Year 3 Year 5 Year
Sales % 828.57 -8.78 -12.74
EPS % NM NM NM
Dividend % NM NM NM
REVENUE
Quarters 1995 1996 1997 1998
MAR 53 0 0 205
JUN 79 27 150 120
SEP 71 11 80
DEC 65 18 290
Totals 268 56 520 325
Note: Units in Thousands of U.S. Dollars
EARNINGS PER SHARE
Quarters 1995 1996 1997 1998
MAR -0.150 -0.120 -0.110 -0.110
JUN -0.190 -0.140 -0.100 -0.100
SEP -0.210 -0.100 -0.100
DEC -0.310 -0.180 -0.088
Totals -0.860 -0.540 -0.398 -0.210
Note: Units in U.S. Dollars
Equity: Common Stock $.01 Par, 6/98, 30M auth., 12,148,376 issd., less 17,340 shares in Treas. @ $242K. Insiders own approx. 26%. 2 others own approx. 23%. 12/95, Common shares issd. per distribution of IGI, Inc. Common Stock (Basis :1-for-1). (As of 12/97) Long term debt: $24K in capital leases. Preferred Stk. $.01 Par, 6,500 auth., 6,500 issd.
Analyst Footnotes: All share amounts prior to distribution are pro-forma. 2/97, Co. issd. 1.2M Common shs. in private placement.
Dividend Reinvestment Plan Available: NO
SELECTED INCOME STATEMENT ITEMS
ANNUAL YEAR TO DATE
12 MONTHS
ENDING
12/31/95 12 MONTHS
ENDING
12/31/96 12 MONTHS
ENDING
12/31/97 6 MONTHS
ENDING
06/30/97 6 MONTHS
ENDING
06/30/98
Revenue 268 56 520 150 325
Operating Expenses 7,013 5,590 5,311 2,607 2,529
Operating Income -6,745 -5,534 -4,791 -2,457 -2,204
Non-Operating Income 0 138 245 113 212
Non-Operating Expenses -1,750 0 0 0 0
Income Before Taxes -8,495 -5,396 -4,546 -2,344 -1,992
Income Taxes 0 98 0 0 0
Income After Taxes -8,495 -5,494 -4,546 -2,344 -1,992
Adjustments to Income 0 0 0 0 -455
Inc. for Primary EPS -8,495 -5,494 -4,546 -2,344 -2,447
Pri/Bas EPS Ex. XOrd -0.855 -0.542 -0.390 -0.206 -0.203
Disc Opns + Xord Items 0 0 0 0 0
Pri/Bas EPS In. XOrd -0.855 -0.542 -0.390 -0.206 -0.203
Primary/Basic Avg Sh 9,937.94 10,132.90 11,667.43 11,390.53 12,066.72
Common Dividends/Shr 0.000 0.000 0.000 0.000 0.000
Dilutd EPS Excl XOrd -0.855 -0.542 -0.390 -0.206 -0.203
Dilutd EPS Incl XOrd -0.855 -0.542 -0.390 -0.206 -0.203
Note: Units in Thousands of U.S. Dollars except for per share items.
SELECTED BALANCE SHEET ITEMS
YEAR ENDING QUARTER ENDING
12/31/95 12/31/96 12/31/97 06/30/97 06/30/98
Cash & ST Investments 4,634 2,982 3,847 5,846 8,344
Receivables 0 0 217 93 70
Other Current Assets 127 239 239 96 107
Total Current Assets 4,761 3,221 4,303 6,035 8,521
LT Investments 0 0 0 0 0
Fixed Assets 1,401 978 890 936 994
Other LT Assets 1,368 1,523 1,629 1,630 1,589
Total Assets 7,530 5,722 6,822 8,601 11,104
Accounts Payable 392 368 238 350 150
ST Debt & Curr LTD 0 11 11 11 32
Other Current Liab. 39 203 40 89 84
Total Current Liab. 431 582 289 450 266
LT Debt & Cap Leases 0 24 13 18 26
Other LT Liabilities 0 0 0 0 0
Total Liabilities 431 606 302 468 292
Preferred Stock 0 0 0 0 5,998
Common & Paid In Capital 30,287 32,517 38,141 37,589 38,411
Retained Earnings -21,301 -26,796 -31,343 -29,140 -33,335
Other Equity -1,888 -603 -277 -314 -262
Total Equity 7,098 5,118 6,521 8,135 10,812
Shares Outstanding 9,938 10,661 12,012 11,899 12,131
Note: Units in Thousands of U.S. Dollars.
SELECTED STATEMENT OF CASH FLOW ITEMS
(INDIRECT Method)
ANNUAL YEAR TO DATE
12 MONTHS
ENDING
12/31/95 12 MONTHS
ENDING
12/31/96 12 MONTHS
ENDING
12/31/97 6 MONTHS
ENDING
06/30/97 6 MONTHS
ENDING
06/30/98
Net Income -8,494 -5,495 -4,547 -2,344 -1,992
Depreciation & Amort. 273 328 254 135 132
Non Cash Items 1,364 1,842 588 291 15
Other Operating CF 596 10 -538 -130 274
Total Operating CF -6,261 -3,315 -4,243 -2,048 -1,571
Capital Expenditures -413 -342 -244 -151 -186
Other Investing CF 0 -501 501 501 0
Total Investing CF -413 -843 257 350 -186
Dividends Paid 0 0 0 0 0
Sale (Purch.) of Stock 38 2,007 5,353 5,070 6,269
Net Borrowings 4,172 0 0 -6 -15
Other Financing CF 7,082 0 0 0 0
Total Financing CF 11,292 2,007 5,353 5,064 6,254
Exchange Rate Effect 0 0 0 0 0
Net Change In Cash 4,618 -2,153 1,366 3,365 4,497
Note: Units in Thousands of U.S. Dollars.
Copyright 1996-1998 Market Guide Inc., 2001 Mar
|
